Accordingly, we speculate that the TME prognostic model may affect BC survival outcomes by reshaping the tumor immune microenvironment, such as altering ECM, CD8+ T cell and these above-mentioned immunosuppressive cells, etc. Here, CD8A is linked to breast cancer.